Friday, September 20, 2013

Coverage: CBSA's Rocky Mountain Life Science Investor and Partnering Conference 2013

Quoting: "The vetted companies came from Colorado, Arizona, Utah, New Mexico and Montana with hopes of attracting investment to move their products – focused on cancer, multiple sclerosis, diabetes, Lyme disease, wound repair and a host of other bioscience challenges – toward commercialization and profitability.

The day-long conference kicked off with a breakfast keynote “fireside chat” featuring Kyle Lefkoff, founder of Boulder Ventures, moderating a discussion with the leaders of two of Colorado’s premier publicly traded life science companies – Patrick Mahaffy, CEO and co-founder of Clovis Oncology and Ron Squarer, CEO of Array BioPharma, who shared their views on the state of Colorado’s bioscience industry"

Link to the posting

Quoting: "Executives of two Boulder-based biopharmaceutical companies said Thursday that early-stage pharma business in Colorado is hampered by the lack of a stable core that can be built around. Speaking at the Rocky Mountain Life Science Investor and Partnering Conference at the Ritz-Carlton, the two said they do their best in an environment that can be at once frustrating and invigorating."

Link to the posting

No comments:

Post a Comment